X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (282) 282
Book Chapter (9) 9
Book / eBook (5) 5
Book Review (4) 4
Conference Proceeding (3) 3
Magazine Article (3) 3
Patent (3) 3
Publication (3) 3
Archival Material (1) 1
Newspaper Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (127) 127
index medicus (115) 115
nanotopography (55) 55
stem cells (53) 53
differentiation (52) 52
nanoscience & nanotechnology (50) 50
engineering, biomedical (44) 44
materials science, biomaterials (42) 42
animals (36) 36
surface properties (36) 36
cells, cultured (33) 33
biomaterials (32) 32
topography (31) 31
in-vitro (30) 30
adhesion (29) 29
cell differentiation (29) 29
materials science, multidisciplinary (27) 27
female (26) 26
male (26) 26
mesenchymal stem-cells (26) 26
cell biology (25) 25
tissue engineering (24) 24
biomedical materials (23) 23
cell adhesion (23) 23
mesenchymal stem cells (23) 23
chemistry, multidisciplinary (22) 22
mechanotransduction (22) 22
extracellular-matrix (21) 21
nanotechnology (21) 21
cells (20) 20
mesenchymal stem cells - cytology (20) 20
osteogenesis (20) 20
aged (19) 19
biochemistry (19) 19
biocompatible materials - chemistry (19) 19
biotechnology & applied microbiology (19) 19
gene expression (19) 19
osteoblasts - cytology (19) 19
biological products (18) 18
chemistry, physical (18) 18
gene-expression (18) 18
multidisciplinary sciences (18) 18
osteoblasts (18) 18
proteins (18) 18
bone (17) 17
fibroblasts (17) 17
proliferation (17) 17
middle aged (16) 16
nanostructures - chemistry (16) 16
nanotechnology - methods (16) 16
tissue engineering - methods (16) 16
cytoskeleton (15) 15
dentistry (15) 15
fibronectin (15) 15
nanostructure (15) 15
nanostructures (15) 15
signal transduction (15) 15
adhesion formation (14) 14
analysis (14) 14
expression (14) 14
phenotype (14) 14
biocompatibility (13) 13
cell line (13) 13
microscopy, electron, scanning (13) 13
abridged index medicus (12) 12
fibroblasts - cytology (12) 12
geopolitics (12) 12
nanobioscience (12) 12
osteogenesis - physiology (12) 12
osteogenic differentiation (12) 12
regeneration (12) 12
regenerative medicine (12) 12
stem-cells (12) 12
surfaces (12) 12
topographical control (12) 12
advanced basic science (11) 11
biochemistry & molecular biology (11) 11
cell adhesion - physiology (11) 11
cell behavior (11) 11
cytoskeleton - metabolism (11) 11
gene expression regulation (11) 11
matrix (11) 11
mesenchymal stem cell (11) 11
mesenchymal stem cells - metabolism (11) 11
mesenchyme (11) 11
metabolomics (11) 11
nanoscale topography (11) 11
stem cells - cytology (11) 11
activation (10) 10
bacteria (10) 10
biology (10) 10
bone-formation (10) 10
cell proliferation (10) 10
fibroblasts - metabolism (10) 10
materials testing (10) 10
mice (10) 10
microscopy, atomic force (10) 10
morphology (10) 10
nanostructures - ultrastructure (10) 10
physics, applied (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article
by Mehanna, Hisham and Robinson, Max and Hartley, Andrew and Kong, Anthony and Foran, Bernadette and Fulton-Lieuw, Tessa and Dalby, Matthew and Mistry, Pankaj and Sen, Mehmet and O'Toole, Lorcan and Al Booz, Hoda and Dyker, Karen and Moleron, Rafael and Whitaker, Stephen and Brennan, Sinead and Cook, Audrey and Griffin, Matthew and Aynsley, Eleanor and Rolles, Martin and De Winton, Emma and Chan, Andrew and Srinivasan, Devraj and Nixon, Ioanna and Grumett, Joanne and Leemans, C René and Buter, Jan and Henderson, Julia and Harrington, Kevin and McConkey, Christopher and Gray, Alastair and Dunn, Janet and Moleron, Rafael and McArdle, Orla and Dyker, Karen and Al Booz, Hoda and O'Toole, Lorcan and Cook, Audrey and Husband, David and Loo, Vivienne and Soe, Win and Aynsley, Eleanor and Sridhar, Thiagarajan and Jankowska, Petra and Joseph, Mano and Geropantas, Konstantinos and Vaidya, Deepali and Griffin, Matthew and Hartley, Andrew and Vijayan, Rengarajan and Hwang, David and Harrington, Kevin and Pettit, Laura and Whitaker, Stephen and De Winton, Emma and Rolles, Martin and Brennan, Sinéad and Sen, Mehmet and Mendes, Ruheena and Forster, Martin and Chan, Andrew and Evans, Mererid and Buter, Jan and Srinivasan, Devraj and Foran, Bernie and Nankivell, Paul and Bryant, Jennifer and Sharma, Neil and Spruce, Rachel and Brooks, Jill and Batis, Nikos and Roques, Tom and Bidmead, Margaret and Yang, Huiqi and Nutting, Christopher and Tyler, Justine and Henderson, Julia and Baines, Helen and Gasnier, Anne and Miles, Elizabeth and Clark, Catharine and De-ESCALaTE HPV Trial Group and De-ESCALaTE HPV Trial Grp
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10166, pp. 51 - 60
The incidence of human papillomavirus (HPV)-positive oropharyngeal cancer, a disease affecting younger patients, is rapidly increasing. Cetuximab, an epidermal... 
yes | DYSPHAGIA | HEAD | MEDICINE, GENERAL & INTERNAL | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | P16 STATUS | ASSOCIATION | EXPRESSION | NECK-CANCER | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Cetuximab - therapeutic use | Radiotherapy, Intensity-Modulated - adverse effects | Squamous Cell Carcinoma of Head and Neck - virology | Cetuximab - adverse effects | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Female | Acute Disease | Chemoradiotherapy - methods | Papillomavirus Infections - complications | Drug Administration Schedule | Risk Assessment | Radiotherapy, Intensity-Modulated - methods | Kaplan-Meier Estimate | Treatment Outcome | Oropharyngeal Neoplasms - virology | Cisplatin - therapeutic use | Cisplatin - adverse effects | Cetuximab - administration & dosage | Squamous Cell Carcinoma of Head and Neck - therapy | Neoplasm Staging | Papillomaviruses | Radiotherapy | Throat cancer | Papillomavirus infections | Head | Intravenous administration | Toxicity | Health risks | Risk | Radiation therapy | FDA approval | Cancer therapies | Patients | Evidence-based medicine | Cisplatin | Quality of life | Human papillomavirus | Randomization | Epidermal growth factor | Motivation | Oropharyngeal cancer | Head and neck | Head & neck cancer | Growth factors | Smoking | Cancer | Tumors
Journal Article
European heart journal, ISSN 0195-668X, 09/2019, Volume 40, Issue 33, pp. 2801 - 2809
textabstractAims The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related... 
Alirocumab • Prevention • MI types • Mortality | Prevention | MI types | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | THERAPY | UNIVERSAL DEFINITION | CHOLESTEROL | Mortality | DISEASE | CLASSIFICATION | Alirocumab | EVOLOCUMAB | Fast Track Clinical Research
Journal Article
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
Journal Article